2,3-dinor-11β-Prostaglandin F2α-d9

Formulation: A solution in ethanol

Formal Name: (Z)-5-((1R,2R,3S,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl-5,5,6,6,7,7,8,8,8-d9)cyclopentyl)pent-3-enoic acid

Purity: ≥99% deuterated forms (d1-d9)

Formula Markup: C18H21D9O5

Formula Weight: 335,5

Shelf life (days): 365

Notes: 2,3-dinor-11β-PGF2α-d9 is intended for use as an internal standard for the quantification of 2,3-dinor-11β-PGF2α (Item No. 16530) by GC- or LC-MS. 2,3-dinor-11β-PGF2α is a metabolite of PGD2 (Item No. 12010).{418,15162} Urinary excretion of 2,3-dinor-11β-PGF2α is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels.{60971} 2,3-dinor-11β-PGF2α levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function.{60972}

• Artikelnummer: CAY9000603-50
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 9000603-50
• Green Labware: Nein
• Verpackungseinheit: 50 µg
• Mengeneinheit: STK
• Methode: GC-MS, LC-MS, Isotopenmarkierung